logo
Plus   Neg
Share
Email

Rolls-Royce Names Panos Kakoullis CFO And Executive Director, Effective May 3

Rolls-Royce Holdings plc. (RYCEF.PK,RR.L,RYCEY.PK) announced Monday the appointment of Panos Kakoullis as Chief Financial Officer and Executive Director, succeeding Stephen Daintith who is leaving the company as announced last year.

Daintith will leave Rolls-Royce on March 19, shortly after the publication of the Group's full year 2020 results, while Kakoullis will take up his new role on May 3.

To support the company in the period of transition, Ben Fidler, who is currently acting as Deputy CFO and joined the Executive Team effective January 1, will be appointed as Interim CFO.

Fidler, who joined Rolls-Royce in 2017 from Deutsche Bank, will continue to carry out his current responsibilities as Vice President of Business Performance in addition to his new role.

The new CFO Kakoullis more recently joined PA Consulting. He started his career at Deloitte, and was, until May 2019, Global Head of Deloitte's Audit and Assurance Practice.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney World, the Orlando, Florida-based entertainment complex, is easing the health safety guidelines that were rolled out to prevent the spread of the ongoing COVID-19 pandemic. The complex is ending temperature checks in a phased manner following the advice of the Centers for Disease Control and Prevention (CDC) and local health officials. Frito-Lay North America, the convenient foods division of food and beverages giant PepsiCo, Inc., is recalling select Ruffles All Dressed Potato Chips citing the possible presence of undeclared milk ingredients, a known allergen, the U.S. Food and Drug Administration said. According to the agency, the recalled products may have distributed regionally to Walmart's Sam's Club Warehouses. Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that they have initiated the Biologics License Application (BLA) process with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. The companies initiated...
Follow RTT